Literature DB >> 28861341

Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea.

Zhi-Xin Yan1, Yi Luo1, Ning-Fei Liu2.   

Abstract

AIM: To investigate angiopoietin-2 (Ang-2)/Tie2 signaling pathway involving in inflammatory angiogenesis.
METHODS: Three interrupted 11-0 nylon sutures were placed into the corneal stroma of BALB/c mice (6wk old) to induce inflammatory neovascularization. Expression of Ang-2 and Tie2 protein on neovascularization were examined by immunofluorescence. The dynamic expression of Ang-2 mRNA on neovascularization was examined by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Finally, the mouse model of suture-induced corneal neovascularization was used to assess the role of Ang-2/Tie2 signaling pathway in inflammatory angiogenesis by systemic application of L1-10, an Ang-2 specific inhibitor. Mouse corneal hemangiogenesis were evaluated by whole mount immunofluorescence.
RESULTS: Both Ang-2 and Tie2 were expressed on newly generated blood vessels in inflammatory cornea. Ang-2 expression was gradually upregulated around 2wk following injury, which was concurrent with an increased number of blood vessels. Blockade of Ang-2/Tie2 signaling pathway obviously promoted angiogenesis in inflammatory cornea.
CONCLUSION: Ang-2/Tie2 signaling pathway seems to play an important role during angiogenesis in inflammatory cornea. This may open new therapeutic applications in pathological processes such as corneal graft survival, wound healing and carcinogenesis.

Entities:  

Keywords:  Tie2; angiogenesis; angiopoietin-2; inflammation

Year:  2017        PMID: 28861341      PMCID: PMC5554834          DOI: 10.18240/ijo.2017.08.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature.

Authors:  Hai Tao Yuan; Chitra Suri; David N Landon; George D Yancopoulos; Adrian S Woolf
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

3.  Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.

Authors:  Elena Bogdanovic; Vicky P K H Nguyen; Daniel J Dumont
Journal:  J Cell Sci       Date:  2006-08-08       Impact factor: 5.285

4.  Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by the specific inhibitor L1-10.

Authors:  Zhi-Xin Yan; Zhao-Hua Jiang; Ning-Fei Liu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival.

Authors:  Romina Fasciani; Luigi Mosca; Maria Ilaria Giannico; Simone Antonio Ambrogio; Emilio Balestrazzi
Journal:  Int Ophthalmol       Date:  2014-04-09       Impact factor: 2.031

Review 6.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Authors:  A M Isidori; M A Venneri; D Fiore
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256

7.  Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.

Authors:  Tina Dietrich; Jasmine Onderka; Felix Bock; Friedrich E Kruse; Dörte Vossmeyer; Roland Stragies; Grit Zahn; Claus Cursiefen
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.

Authors:  Felix Bock; Jasmine Onderka; Tina Dietrich; Björn Bachmann; Bronislaw Pytowski; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-02       Impact factor: 3.117

9.  Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis.

Authors:  Sarah L Tressel; Hyongbum Kim; Chih-Wen Ni; Kyunghwa Chang; Juan C Velasquez-Castano; W Robert Taylor; Young-Sup Yoon; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-04       Impact factor: 8.311

10.  Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.

Authors:  Felix Bock; Jasmine Onderka; Tina Dietrich; Björn Bachmann; Friedrich E Kruse; Matthias Paschke; Grit Zahn; Claus Cursiefen
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

View more
  8 in total

1.  The Key Role of VEGF in the Cross Talk between Pterygium and Dry Eye and Its Clinical Significance.

Authors:  Chang Liu; Yiyue Song; Xiaoran Wang; Zhaoguang Lai; Chaoyang Li; Pengxia Wan; Nuo Xu; Danping Huang; Yizhi Liu; Zhichong Wang
Journal:  Ophthalmic Res       Date:  2020-01-10       Impact factor: 2.892

2.  Capillary rarefaction and altered renal development: the imbalance between pro- and anti-angiogenic factors in response to angiotensin II inhibition in the developing rat kidney.

Authors:  Kee Hwan Yoo; Hyung Eun Yim; Eun Soo Bae; Young Sook Hong
Journal:  J Mol Histol       Date:  2018-02-13       Impact factor: 2.611

3.  Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.

Authors:  Qing Xu; Chaoju Gong; Lei Qiao; Ruifang Feng; Haiyang Liu; Yalu Liu; Liu Yang; Wei Fan; Lina Guan; Jie Li; Yipeng Zhang; Suyan Li
Journal:  BMC Ophthalmol       Date:  2022-05-18       Impact factor: 2.086

4.  Latent Sensitization in a Mouse Model of Ocular Neuropathic Pain.

Authors:  Jooyoung Cho; Nicholas Bell; Gregory Botzet; Paras Vora; Benjamin J Fowler; Renee Donahue; Heather Bush; Bradley K Taylor; Romulo J C Albuquerque
Journal:  Transl Vis Sci Technol       Date:  2019-03-26       Impact factor: 3.283

Review 5.  Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine.

Authors:  Cheng Zhang; Ning Wang; Hor-Yue Tan; Wei Guo; Sha Li; Yibin Feng
Journal:  Integr Cancer Ther       Date:  2018-05-28       Impact factor: 3.279

Review 6.  Pathological angiogenesis and inflammation in tissues.

Authors:  Ji-Hak Jeong; Uttam Ojha; You Mie Lee
Journal:  Arch Pharm Res       Date:  2020-11-23       Impact factor: 4.946

7.  Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway.

Authors:  Xiao Li; Yan Li; Yuan Wang; Fuhong Liu; Yanjun Liu; Jiangjiu Liang; Rucai Zhan; Yue Wu; He Ren; Xiuyuan Zhang; Ju Liu
Journal:  Exp Ther Med       Date:  2022-03-31       Impact factor: 2.447

Review 8.  Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.

Authors:  Dongqing Guo; Colin E Murdoch; Tianhua Liu; Jia Qu; Shihong Jiao; Yong Wang; Wei Wang; Xing Chen
Journal:  Front Pharmacol       Date:  2018-04-26       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.